Elevated protein carbonyls and lipid peroxidation products correlating with myeloperoxidase in tracheal aspirates from premature infants

Pediatric Research

Volumn 47, Issue 5, 2000, Pages 640-645

  Buss, I Hendrikje ^a   Darlow, Brian A ^a   Winterbourn, Christine C ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; MALONALDEHYDE; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CHRONIC LUNG DISEASE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; NEWBORN; PREMATURITY; PRIORITY JOURNAL; VERY LOW BIRTH WEIGHT;

EID: 0034062242     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200005000-00014     Document Type: Article

References (43)

1. Zimmerman JJ 1995 Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin Perinatol 22:429-457
2. Saugstad OD 1996 Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr 85:1-4
3. Rao RA 1996 Oxygen free radicals and retinopathy of prematurity. Br J Ophthalmol 80:387
4. Kelly FJ 1993 Free Radical disorders of preterm infants. Br Med Bull 49:668-678
5. Frank L, Sosenko IRS 1987 Development of lung antioxidant enzyme system in late gestation: Possible implications for the prematurely born infant. J Pediatr 110:9-14
6. Lubec G, Widnes JA, Hayde M, Menzel D, Pollak A 1997 Hydroxyl radical generation in oxygen-treated infants. Pediatrics 100:700-704
7. Banks BA, Ischiropoulos H, McClelland M, Ballard PL, Ballard RA 1998 Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics 101:870-874
8. Nemeth I, Boda D 1994 Blood glutathione redox ratio as a parameter of oxidative stress in premature infants with IRDS. Free Radic Biol Med 16:347-353
9. Smith CV, Hansen TN, Martin NE, McMicken HW, Elliot SJ 1993 Oxidant stress responses in premature infants during exposure to hyperoxia. Pediatr Res 34:360-365
10. Wispe JR, Bell EF, Roberts RJ 1985 Assessment of lipid peroxidation in newborn infants and rabbits by measurements of expired ethane and pentane: Influence of parenteral lipid infusion. Pediatr Res 19:374-379
11. Pitkänen OM, Hallman M, Andersson SM 1990 Correlation of free oxygen radical-induced lipid peroxidation with outcome in very low birth weight infants. J Pediatr 116:760-764
12. Varsila E, Hallman M, Andersson S 1994 Free-radical-induced lipid peroxidation during the early neonatal period. Acta Paediatr 83:692-695
13. Varsila E, Pitkanen O, Hallman M, Andersson S 1994 Immaturity-dependent free radical activity in premature infants. Pediatr Res 36:55-59
14. Stadtman ER 1990 Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med 9:315-325
15. Reznick AZ, Cross CE, Hu ML, Suzuki YJ, Khwaja S, Safadi A, Motchnik PA, Packer L, Halliwell B 1992 Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation. Biochem J 286:607-611
16. Blakeman DP, Ryan TP, Jolly RA, Petry TW 1995 Diquat-dependent protein carbonyl formation. Identification of lipid-dependent and lipid-independent pathways. Biochem Pharmacol 50:929-935
17. Gladstone IM Jr, Levine RL 1994 Oxidation of proteins in neonatal lungs. Pediatrics 93:764-768
18. Varsila E, Pesonen E, Andersson A 1995 Early protein oxidation in the neonatal lung is related to development of chronic lung disease. Acta Paediatr 84:1296-1299
19. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DKI, Gluck L 1983 Elastase and α1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J Clin Invest 72:656-666
20. Sluis KB, Darlow BA, Vissers MCM, Winterbourn CC 1994 Proteinase-antiproteinase balance in tracheal aspirates from neonates. Eur Respir J 7:251-259
21. Groneck P, Speer CP 1995 Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child 73:F1-F3
22. Contreras M, Hariharan N, Lewandoski JR, Ciesielski W, Koscik R, Zimmerman JJ 1996 Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia. Crit Care Med 24:29-37
23. Groneck P, Gotze-Speer B, Opperman M, Eiffert H, Speer CP 1994 Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high risk preterm neonates. Pediatrics 93:712-718
24. Jones CA, Cayabyab RG, Kwong KYC, Stotts C, Wong B, Hamdan H, Minoo P, deLemos RA 1996 Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: A possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 39:966-975
25. Jackson TC, Chi EY, Wilson CB 1987 Sequence of inflammatory cell migration into lung during recovery from hyaline membrane disease in premature newborn monkeys. Am Rev Resp Dis 135:937-940
26. Merritt TA, Stuard ID, Puccia J, Wood B, Edwards DK, Finkelstein J, Shirpiro DL 1981 Newborn tracheal aspirate cytology: Classification during respiratory distress syndrome and bronchopulmonary dysplasia. J Pediatr 98(6):949-956
27. Merritt TA, Hallman M 1988 Interactions in the immature lung: Protease-antiprotease mechanism of lung injury. In: Anonymous Contemporary Issues in Fetal and Neonatal Medicine 4: Bronchopulmonary Dysplasia. Blackwell Scientific, Boston, pp 117-130
28. Speer CP, Ruess D, Harms K, Herting E, Gefeller O 1993 Neutrophil elastase and acute pulmonary damage in neonates with severe respiratory distress syndrome. Pediatrics 91:794-799
29. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD 1984 Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 130:817-821
30. Weiss SJ 1989 Tissue destruction by neutrophils. N Engl J Med 320:365-376
31. Winterbourn CC 1990 Neutrophil oxidants: production and reactions. In: Das DK, Essman WB (eds) Oxygen Radicals: Systemic Events and Disease Processes, 1st Ed. Karger, Basel, pp 31-70
32. Darlow BA, Sluis KB, Inder TE, Winterbourn CC 1997 Endotracheal suctioning of the neonate: balancing clinical and research needs. Pediatr Pulmonol 23:217-221
33. Young IS, Trimble ER 1991 Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 28:504-508
34. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG, Crystal RG 1986 Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 60:532-538
35. Bozeman PM, Learn DB, Thomas EL 1990 Assay of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. J Immunol Methods 126:125-133
36. Buss H, Chan TP, Sluis KB, Domigan NM, Winterboum CC 1997 Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 23:361-366
37. Winterbourn CC, Chan T, Buss IH, Inder TE, Darlow BA 2000. Protein carbonyls and lipid peroxidation products as oxidation markers in premature infant plasma: Associations with chronic lung disease and retinopathy and effects of selenium supplementation. Pediatr Res (in press)
38. Haslam PL, Baughman RP 1999 Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 14:245-248
39. Dargaville PA, South M, McDougall PN 1999 Comparison of two methods of diagnostic lung lavage in ventilated infants with lung disease. Am J Respir Crit Care Med 160:771-777
40. Dargaville PA, South M, Vervaart P, McDougall PN 1999 Validity of markers of dilution in small volume lung lavage. Am J Respir Crit Care Med 160:778-784
41. 1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonates. J Pediatr 113:727-731
42. Lindner W, Vossbeck S, Hummler H, Pohlandt F 1999 Delivery room management of extremely low birth weight infants: spontaneous breathing or intubation? Pediatrics 103:961-967
43. Halliday HL, Ehrenkranz RA 1999 Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane review). In: The Cochrane Library, Issue 1. Oxford, Update Software